Solvey Schüle1, Jean-Benoît Rossel2, Diana Frey3, Luc Biedermann1, Michael Scharl1, Jonas Zeitz1, Natália Freitas-Queiroz1, Valérie Pittet2, Stephan R Vavricka4, Gerhard Rogler1, Benjamin Misselwitz1. 1. Division of Gastroenterology and Hepatology, University Hospital Zurich and Zurich University, Switzerland. 2. Institut de Médecine Sociale et Préventive Unité d'Evaluation des Soins Bio2/02/185, Switzerland. 3. Division of Rheumatology, University Hospital Zurich and Zurich University, Switzerland. 4. Division of Gastroenterology and Hepatology, University Hospital Zurich and Zurich University, Switzerland; Department of Medicine, Division of Gastroenterology, Triemli Hospital, Zurich, Switzerland.
Abstract
BACKGROUND: Low bone mineral density (BMD) remains a frequent problem in patients with inflammatory bowel diseases (IBD). There is no general agreement regarding osteoporosis screening in IBD patients. METHODS: Cases of low BMD and disease characteristics were retrieved from 3172 patients of the Swiss IBD cohort study. Multivariate logistic regression analysis was conducted for predictive modeling. In a subgroup of 877 patients, 253 dual-energy X-ray absorptiometry (DXA) scans were available for validation. RESULTS: Low BMD was prevalent in 19% of patients. We identified seven predictive factors: type of IBD, age, recent steroid usage, low body mass index, perianal disease, recent high disease activity and malabsorption syndrome. Low BMD could be predicted with a sensitivity of 79% and a specificity of 64%, a positive predictive value (PPV) of 35% and a negative predictive value (NPV) of 93%. The area under the curve of the receiver operating characteristics was 0.78. In the validation cohort we calculated a PPV of 26% and an NPV of 88%. CONCLUSION: We provide a comprehensive analysis of risk factors for low BMD and propose a predictive model with seven clinical variables. The high NPV of models such as ours might help in excluding low BMD to prevent futile investigations.
BACKGROUND: Low bone mineral density (BMD) remains a frequent problem in patients with inflammatory bowel diseases (IBD). There is no general agreement regarding osteoporosis screening in IBD patients. METHODS: Cases of low BMD and disease characteristics were retrieved from 3172 patients of the Swiss IBD cohort study. Multivariate logistic regression analysis was conducted for predictive modeling. In a subgroup of 877 patients, 253 dual-energy X-ray absorptiometry (DXA) scans were available for validation. RESULTS: Low BMD was prevalent in 19% of patients. We identified seven predictive factors: type of IBD, age, recent steroid usage, low body mass index, perianal disease, recent high disease activity and malabsorption syndrome. Low BMD could be predicted with a sensitivity of 79% and a specificity of 64%, a positive predictive value (PPV) of 35% and a negative predictive value (NPV) of 93%. The area under the curve of the receiver operating characteristics was 0.78. In the validation cohort we calculated a PPV of 26% and an NPV of 88%. CONCLUSION: We provide a comprehensive analysis of risk factors for low BMD and propose a predictive model with seven clinical variables. The high NPV of models such as ours might help in excluding low BMD to prevent futile investigations.
Entities:
Keywords:
Osteoporosis; bone mineral density; inflammatory bowel diseases; predictive model
Authors: Jae Hyuk Choi; Eun Soo Kim; Kwang Bum Cho; Kyung Sik Park; Yoo Jin Lee; Sang Min Lee; Yu Jin Kang; Byung Ik Jang; Kyeong Ok Kim Journal: Intest Res Date: 2015-01-29
Authors: Joseph E Tanenbaum; Stephanie T Kha; Edward C Benzel; Michael P Steinmetz; Thomas E Mroz Journal: Spine J Date: 2017-11-15 Impact factor: 4.166
Authors: Solvey Schüle; Jean-Benoît Rossel; Diana Frey; Luc Biedermann; Michael Scharl; Jonas Zeitz; Natália Freitas-Queiroz; Thomas Kuntzen; Thomas Greuter; Stephan R Vavricka; Gerhard Rogler; Benjamin Misselwitz Journal: Medicine (Baltimore) Date: 2017-06 Impact factor: 1.889
Authors: Gaurav Syal; Mariastella Serrano; Animesh Jain; Benjamin L Cohen; Florian Rieder; Christian Stone; Bincy Abraham; David Hudesman; Lisa Malter; Robert McCabe; Stefan Holubar; Anita Afzali; Adam S Cheifetz; Jill K J Gaidos; Alan C Moss Journal: Inflamm Bowel Dis Date: 2021-10-18 Impact factor: 5.325